The team of Peptisyntha, renowned in therapeutic peptides, is highly skilled in solid and solution phase peptides technologies and is able to provide custom-made peptides from preclinical to commercial scale, applying cGMP production, testing and documentation standards in accordance with the strictest FDA and EMEA requirements. Over decades, Peptisyntha has developed specific know-how in innovative peptide technologies.

Girindus, an independent company member of Solvay Organics, is highly skilled in oligonucleotide technologies and custom synthesis of small molecules for therapeutic use.  Girindus can deliver products for preclinical, clinical and commercial scales, complying with cGMP standards.

Solvay Fluororganics, another member of Solvay Organics, develops and manufactures aliphatic fluorinated specialties for agrochemical and pharmaceutical applications. In addition to its standard range portfolio, Solvay Fluororganics also develops also custom-made fluororganic compounds for its customers.

Girindus is a company independent of Solvay in which Solvay has a shareholding of 75%